James D.  Swanson net worth and biography

James Swanson Biography and Net Worth

Insider of Johnson & Johnson

Jim Swanson is Executive Vice President, Chief Information Officer, and member of the Executive Committee for Johnson & Johnson. Based at Johnson & Johnson’s USA headquarters, Jim is responsible for accelerating Johnson & Johnson’s business outcomes and advancing human health with technology and digital innovation.

In his current role, Jim leads the Johnson & Johnson Technology organization, a team of more than 4,000 professionals across 50 countries who are passionate about combining deep scientific expertise with the latest digital solutions to confront some of the most complex healthcare challenges of our time. In addition, Jim and his team are responsible for powering the 144,000 colleagues across Johnson & Johnson and the digital ecosystem that connects the Company to patients and customers.

Jim has an overriding commitment to attracting and growing digital talent across the enterprise and forging external connections across industries and disciplines. He has been known to say he has “the best job in the world” because of his ability to drive positive impact in the world using “tech for good”. Jim, and the organizations he has led, have received industry accolades for their contributions in leadership, application of technology to drive outcomes and deliver business value, best places to work in IT, and support of STEM for emerging talent.

Jim rejoined Johnson & Johnson in 2019 from Bayer Crop Science, where he served as a member of the Executive Leadership Team, Chief Information Officer, and Head of Digital Transformation. Previously, he served as Chief Information Officer at Monsanto for five years, before the company was acquired by Bayer. Prior to that role, Jim spent nine years working as Vice President and Chief Information Officer for Johnson & Johnson Pharmaceutical, where he advanced technology throughout the company’s Research & Development organization.

Earlier in his career, Jim led the Research & Development and Commercial IT organizations at Merck. Jim began as a bench scientist at SmithKline Beecham before transitioning to IT. Throughout his professional life, he has had extensive international experience, including living in the United Kingdom and Germany.

Jim holds a bachelor's degree in Bioscience and Biotechnology and a master's degree in Computer Science, both from Drexel University.

Jim is married and is the proud father of three daughters. In his free time, he enjoys running, biking, skiing, scuba diving, and boating, as well as volunteering with United Way Ready by 21 and the American Heart Association.

What is James D. Swanson's net worth?

The estimated net worth of James D. Swanson is at least $1.44 million as of March 6th, 2023. Mr. Swanson owns 9,215 shares of Johnson & Johnson stock worth more than $1,435,236 as of October 1st. This net worth estimate does not reflect any other assets that Mr. Swanson may own. Learn More about James D. Swanson's net worth.

How old is James D. Swanson?

Mr. Swanson is currently 57 years old. There are 7 older executives and no younger executives at Johnson & Johnson. The oldest executive at Johnson & Johnson is Dr. John C. Reed M.D., Ph.D., Exec. VP of Pharmaceuticals R&D, who is 65 years old. Learn More on James D. Swanson's age.

How do I contact James D. Swanson?

The corporate mailing address for Mr. Swanson and other Johnson & Johnson executives is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. Johnson & Johnson can also be reached via phone at (732) 524-0400. Learn More on James D. Swanson's contact information.

Has James D. Swanson been buying or selling shares of Johnson & Johnson?

James D. Swanson has not been actively trading shares of Johnson & Johnson over the course of the past ninety days. Most recently, James D. Swanson sold 1,062 shares of the business's stock in a transaction on Monday, March 6th. The shares were sold at an average price of $154.66, for a transaction totalling $164,248.92. Following the completion of the sale, the insider now directly owns 9,215 shares of the company's stock, valued at $1,425,191.90. Learn More on James D. Swanson's trading history.

Who are Johnson & Johnson's active insiders?

Johnson & Johnson's insider roster includes Dominic Caruso (VP), Robert Decker (CAO), Joaquin Duato (CEO & Director ), Peter Fasolo (VP), Alex Gorsky (CEO), William Hait (Insider), Ronald Kapusta (CAO), Ashley McEvoy (EVP), Thibaut Mongon (VP), William Perez (Director), Michael Sneed (COO), Paulus Stoffels (VP), James Swanson (Insider), Jennifer Taubert (EVP), Kathryn Wengel (EVP), Joseph Wolk (CFO), and Joseph Wolk (Exec. VP & CFO ). Learn More on Johnson & Johnson's active insiders.

Are insiders buying or selling shares of Johnson & Johnson?

During the last year, insiders at the sold shares 13 times. They sold a total of 348,975 shares worth more than $60,404,781.75. The most recent insider tranaction occured on July, 26th when insider William Hait sold 14,698 shares worth more than $2,528,056.00. Insiders at Johnson & Johnson own 0.2% of the company. Learn More about insider trades at Johnson & Johnson.

Information on this page was last updated on 7/26/2023.

James D. Swanson Insider Trading History at Johnson & Johnson

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/6/2023Sell1,062$154.66$164,248.929,215View SEC Filing Icon  
See Full Table

James D. Swanson Buying and Selling Activity at Johnson & Johnson

This chart shows James D Swanson's buying and selling at Johnson & Johnson by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Johnson & Johnson Company Overview

Johnson & Johnson logo
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Read More

Today's Range

Now: $155.75
Low: $155.35
High: $157.60

50 Day Range

MA: $165.97
Low: $155.75
High: $174.51

2 Week Range

Now: $155.75
Low: $150.11
High: $181.04


7,680,711 shs

Average Volume

6,977,931 shs

Market Capitalization

$404.79 billion

P/E Ratio


Dividend Yield